BIO.B
Bio-Rad Laboratories, Inc. Class B
NYSE · usd
Bio-Rad Laboratories, Inc. Class B (BIO.B) trades at $364.15 (+0.00%) as of 11:07:04 AM EDT on Oct 23, 2026, +35.43% over the past month, with 1.0 days to cover in short interest.
Stock performance
How Bio-Rad Laboratories, Inc. Class B (BIO.B) stock has performed from one day to one year, with its 52-week range.
- 1D
- -0.25%
- 1W
- +24.13%
- 1M
- +35.43%
- YTD
- +17.20%
- 1Y
- +20.12%
- 52-wk range
- $244.54 – $365.08
Key statistics
Today's trading snapshot for BIO.B: day range, open, previous close, volume and market cap.
- Day range
- $364.15 – $364.21
- Open
- $364.21
- Prev close
- $364.15
- Volume
- 231
- Market cap
- —
- Shares out
- 5.06M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Bio-Rad Laboratories, Inc. Class B: P/E, P/S, P/B, ROE and more.
- P/E
- 43.78
- P/S
- 3.76
- P/B
- 1.36
- P/FCF
- 27.57
- ROE
- 3.1%
- ROA
- 2.2%
- Debt/Equity
- 0.17
- Div yield
- 0.00%
As of Oct 14, 2026
8-K filings
Material corporate events Bio-Rad Laboratories, Inc. Class B has disclosed to the SEC on Form 8-K.
- RestructuringAug 4, 2026
The restructuring plan impacts our operations and functions throughout the world and includes the elimination of certain positions, the consolidation of certain functions, and the closure of various facilities.
- Investor communicationsApr 30, 2026
Also on April 30, 2026, the Company posted supplemental earnings materials with respect to its financial results for the quarter ended March 31, 2026 to its website (the "Supplemental Earnings Presentation"), which can be accessed at www.bio-rad.com in the Investor Relations section under the subheading "Events & Presentations".
- Shareholder activismApr 24, 2026
The stockholder proposal regarding dual class capital structure was not approved since the proposal did not receive the affirmative vote of a majority of the voting power of the holders of Class A and Class B Common Stock.
- Investor communicationsFeb 12, 2026
Also on February 12, 2026, the Company posted supplemental earnings materials with respect to its financial results for the quarter ended December 31, 2025 to its website (the "Supplemental Earnings Presentation"), which can be accessed at www.bio-rad.com in the Investor Relations section under the subheading "Events & Presentations."
- Investor communicationsOct 29, 2025
Also on October 29, 2025, the Company posted supplemental earnings materials with respect to its financial results for the quarter ended September 30, 2025 to its website (the "Supplemental Earnings Presentation"), which can be accessed at www.bio-rad.com in the Investor Relations section under the subheading "Events & Presentations."
BIO.B short interest
How heavily BIO.B is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 1.0
- Short interest
- 1
- Avg volume
- 20
As of · reported to FINRA twice monthly.
BIO.B news
The latest news and headlines about Bio-Rad Laboratories, Inc. Class B (BIO.B).
- Neogen (NEOG) Q1 Earnings and Revenues Beat EstimatespositiveZacks Investment Research· Oct 6, 2026
- Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and AutomationpositiveGlobeNewswire Inc.· Oct 6, 2026
- Europe Point of Care Diagnostics Market Size and Forecast, 2021 - 2031 | Market to Reach US$21.4 Billion by 2031 as Rapid Testing and Molecular Innovation Drive 13.4% CAGRpositiveGlobeNewswire Inc.· Oct 5, 2026
- Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGRpositiveGlobeNewswire Inc.· Oct 5, 2026
- Magnetic Beads Market - Global Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 BillionpositiveGlobeNewswire Inc.· Oct 5, 2026
Frequently asked questions
What is the Bio-Rad Laboratories, Inc. Class B (BIO.B) stock price today?
Bio-Rad Laboratories, Inc. Class B (BIO.B) is trading at $364.15 (+0.00% on the day) as of 11:07:04 AM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Bio-Rad Laboratories, Inc. Class B?
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets.
What is the short interest in BIO.B?
As of Sep 30, 2026, BIO.B has 1 shares short and 1.0 days to cover.
What exchange is BIO.B listed on?
Bio-Rad Laboratories, Inc. Class B (BIO.B) trades on NYSE in USD, in the LABORATORY ANALYTICAL INSTRUMENTS industry.
Build with AI
Build an analysis of BIO.B with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a BIO.B analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.